neoplasm
• 12 of 130 mice develop tumors, with a latency period from 7 to 19 months and median of 14 months; most are females with one male developing a mammary gland tumor
• tumors are subcutaneous and located along the ventral or ventral-lateral surface from the neck to the inguinal region
• tumors are mammary adenocarcinoma or carcinoma, exhibiting trabecular/papillary or well-differentiated squamous cell morphology
• all tumors are malignant
• tumors do not undergo loss of heterozygosity and exhibit genomic instability
|
endocrine/exocrine glands
• 12 of 130 mice develop tumors, with a latency period from 7 to 19 months and median of 14 months; most are females with one male developing a mammary gland tumor
• tumors are subcutaneous and located along the ventral or ventral-lateral surface from the neck to the inguinal region
• tumors are mammary adenocarcinoma or carcinoma, exhibiting trabecular/papillary or well-differentiated squamous cell morphology
• all tumors are malignant
• tumors do not undergo loss of heterozygosity and exhibit genomic instability
|
integument
• 12 of 130 mice develop tumors, with a latency period from 7 to 19 months and median of 14 months; most are females with one male developing a mammary gland tumor
• tumors are subcutaneous and located along the ventral or ventral-lateral surface from the neck to the inguinal region
• tumors are mammary adenocarcinoma or carcinoma, exhibiting trabecular/papillary or well-differentiated squamous cell morphology
• all tumors are malignant
• tumors do not undergo loss of heterozygosity and exhibit genomic instability
|
skeleton
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
breast cancer | DOID:1612 |
OMIM:114480 |
J:227323 |